Rathbones Group PLC
Source: SEC Form 13F · as of Mar 2026Rathbones Group PLC holds 16 biotech & pharma companies tracked by BioSniper, totaling $6.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$6.8M
BioSniper AIPage context preserved
Prepared research question
What matters most for PTC THERAPEUTICS, INC. (PTCT)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| PTCTPTC THERAPEUTICS, INC. | 23,500 | $1.6M |
| IBRXImmunityBio, Inc. | 153,420 | $1.2M |
| ORMPORAMED PHARMACEUTICALS INC. | 233,018 | $792K |
| MRNAModerna, Inc. | 13,778 | $700K |
| DFTXDefinium Therapeutics Inc. | 30,200 | $571K |
| GILDGILEAD SCIENCES, INC. | 2,835 | $395K |
| JAZZJazz Pharmaceuticals plc | 1,349 | $255K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,580 | $253K |
| KALVKalVista Pharmaceuticals, Inc. | 10,922 | $220K |
| MESOMesoblast Limited | 14,017 | $216K |
| EXELEXELIXIS, INC. | 4,847 | $208K |
| EVAXEvaxion A/S | 45,723 | $170K |
| BMEABiomea Fusion, Inc. | 37,000 | $57K |
| LCTXLineage Cell Therapeutics, Inc. | 35,000 | $55K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 12,854 | $45K |
| AUTLAutolus Therapeutics plc | 28,050 | $39K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.